文献速递乳房整形与再造

两阶段扩张器植入乳房再造术后需再手术的并发症:结局的批判性分析

Complications After Two-Stage Expander Implant Breast Reconstruction Requiring Reoperation: A Critical Analysis of Outcomes.
PubMed 文献 · Ann Plast Surg · 2018-01-01

回顾性分析2006年12月至2015年8月单一术者连续282例患者共453侧乳房再造,其中39例患者45侧乳房因术后并发症需再手术。再手术与更高体重指数(29 vs 24,P<0.001)、更高组织扩张器初始注水量(299 mL vs 169 mL,P<0.001)及术前放疗(31% vs 13%,P=0.001)相关,并发症以致感染(60%)为主,超过四分之一再手术患者最终失去植入物。

要点

  • 再手术与更高体重指数(29 vs 24,P<0.001)、更高扩张器初始注水量(299 mL vs 169 mL,P<0.001)及术前放疗(31% vs 13%,P=0.001)相关。
  • 导致再手术的并发症包括感染(60%)、乳房切除皮瓣坏死(27%)和扩张器经薄皮瓣外露(11%)。
  • 再手术处理中取出并更换扩张器17例(38%),自体重建16例(36%),取出未更换12例(27%)。

核心结论

  • 感染性并发症(蜂窝织炎和脓肿形成)占扩张器植入乳房再造术后需再手术的大多数病例。
  • 超过四分之一再手术患者最终失去植入物。
  • 两阶段扩张器植入乳房再造患者应就被告知发生并发症时可能需要再手术的可能性进行适当咨询。

研究设计与样本

  • 回顾性分析2006年12月至2015年8月由资深作者连续行组织扩张器植入乳房再造的患者。
  • 共分析282例患者、453侧植入物乳房再造。
  • 收集人口学资料(年龄、体重指数、合并症、吸烟史、乳房放疗史)及手术因素(再造时机:即刻vs延迟;扩张器位置:全肌肉下vs联合脱细胞真皮基质)。

主要发现

  • 39例患者、45侧乳房在发生术后并发症后需再手术。
  • 再手术与更高体重指数(29 vs 24,P<0.001)、更高扩张器初始注水量(299 mL vs 169 mL,P<0.001)及术前放疗(31% vs 13%,P=0.001)相关。
  • 导致再手术的并发症为感染(60%)、乳房切除皮瓣坏死(27%)和扩张器经薄皮瓣外露(11%)。
  • 再手术处理:取出并更换扩张器17例(38%),自体重建16例(36%),取出未更换12例(27%)。

临床怎么用

  • 作者认为两阶段扩张器植入乳房再造患者应就被告知发生并发症时可能需要再手术的可能性进行适当咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage expander implant breast reconstruction is commonly performed after mastectomy. Salvage and long-term outcomes after development of complications have not been well described. We examined a single surgeon's experience to study the rate of reoperation secondary to complications after first-stage expander placement and to evaluate their outcomes. Better understanding of salvage techniques may help guide future management. METHODS: We performed a retrospective analysis of consecutive patients who underwent placement of a tissue expander (TE) for breast reconstruction between December 2006 and August 2015 with the senior author. Patient demographics including age, body mass index, medical comorbidities, history of smoking, and history of radiation to the breast were collected. Surgical factors including timing of reconstruction (immediate vs delayed) and location of TE (total submuscular vs with acellular dermal matrix) were recorded. Complications were analyzed, as were patients who underwent reoperation in the setting of developing a complication. RESULTS: We analyzed 282 patients who underwent 453 implant-based breast reconstructions. Of these, 39 patients and 45 breasts required a reoperation after development of a postoperative complication. Return to the operating room was associated with higher body mass index (29 vs 24, P < 0.001), higher TE initial fill volume (299 mL vs 169 mL, P < 0.001), and preoperative radiation (31% vs 13%, P = 0.001). Complications resulting in reoperation included infection (60%), mastectomy skin necrosis (27%), and TE extrusion through thin mastectomy skin (11%). The affected TE was removed and exchanged in 17 patients (38%), autologous flap reconstruction occurred in 16 patients (36%), and TE was explanted without replacement in 12 patients (27%). CONCLUSIONS: Infectious complications including cellulitis and abscess formation accounted for most cases requiring reoperation after TE placement for breast reconstruction. More than a quarter of patients who underwent a reoperation ultimately lost their implants. Patients undergoing two-stage expander implant breast reconstruction should be appropriately counseled regarding the possibility of requiring a reoperation in the setting of developing a complication.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Sue GR, Sun BJ, Lee GK, et al. Complications After Two-Stage Expander Implant Breast Reconstruction Requiring Reoperation: A Critical Analysis of Outcomes. Ann Plast Surg. 2018. PMID: 29489547. doi:10.1097/SAP.0000000000001382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。